Emcure Pharmaceuticals receives upgrade in credit ratings from CRISIL
Emcure Pharmaceuticals has received upgrade in credit ratings from CRISIL for bank facilities of Rs 2,475.43 crore of the company as under:
Long term rating - CRISIL AA-/ Stable
Short term rating - CRISIL A1+
CKK Retail Mart IPO Allotment Status Online
5 mins read . Jan 30, 2026
NFP Sampoorna Foods IPO Allotment Status Online
4 mins read . Jan 30, 2026
Hannah Joseph IPO Allotment Status Online
5 mins read . Jan 30, 2026
Explore our products
Unlimited Trading starting at ₹249 ₹0
Open Trading Account
